All Deals
July 1, 2026 - Deals
Venice AI Secures $65 Million Series A Investment At $1 Billion Valuation
Venice AI, a privacy-focused AI platform offering access to more than 200 AI models, raised a $65 million Series A round at a $1 billion valuation, making it a unicorn in its first external funding round. The financing was led by Dragonfly, with participation from Coinbase Ventures, North Island Ventures, and others, and will be used to purchase GPUs and build the company's own data centers. CEO Erik Voorhees said Venice AI is already profitable, with annualized run-rate revenue exceeding $70 million, as the company continues to grow its privacy-first alternative to mainstream AI platforms.
FOUNDER: Erik Voorhees
INVESTORS: Dragonfly, Coinbase Ventures, North Island Ventures
ROUND: Series A
AMOUNT: $65,000,000
VALUATION: $1,000,000,000
HQ: Sheridan, Wyoming
#VentureCapital #VeniceAI #ErikVoorhees #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC